These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 6803060

  • 1. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL, van Breda Vriesman PJ, Terpstra JL.
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [Abstract] [Full Text] [Related]

  • 2. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG, MacDonald R, Toledo-Pereyra LH, Fox B.
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract] [Full Text] [Related]

  • 3. New avenues in the use of cyclosporine for transplantation. Graft and donor pretreatment.
    Cederna J, Toledo-Pereyra LH, Gof S, Rios A, MacKenzie GH, Gordon DA.
    Immunol Commun; 1984 Jun; 13(6):523-38. PubMed ID: 6398274
    [Abstract] [Full Text] [Related]

  • 4. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W, Novick AC, Stowe N, Magnusson M, Straffon RA.
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [Abstract] [Full Text] [Related]

  • 5. Donor pretreatment with cyclophosphamide and methylprednisolone.
    Brom HL, van Breda Vriesman PJ.
    Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773
    [No Abstract] [Full Text] [Related]

  • 6. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ, Buurman WA, Vegt PA, Greep JM, Jeekel J.
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [Abstract] [Full Text] [Related]

  • 7. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R, Swistel A, Lorieo D, Fitzpatrick HF.
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract] [Full Text] [Related]

  • 8. The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.
    Swistel AJ, McCabe RE, Lorieo DR, Wildstein A, Fitzpatrick HF.
    Transplant Proc; 1979 Sep; 11(3):1673-5. PubMed ID: 388773
    [No Abstract] [Full Text] [Related]

  • 9. Donor pretreatment in cadaver renal transplantation.
    Zincke H, Woods JE.
    Surg Gynecol Obstet; 1977 Aug; 145(2):183-8. PubMed ID: 327596
    [Abstract] [Full Text] [Related]

  • 10. Developing ways of reducing allograft immunogenicity.
    Guttmann RD.
    Can Med Assoc J; 1981 Jan 15; 124(2):143-5. PubMed ID: 7006782
    [No Abstract] [Full Text] [Related]

  • 11. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD, Morehouse DD, Meakins JL, Klassen J, Knaack J, Beaudoin JG.
    Kidney Int Suppl; 1978 Jun 15; (8):S99-102. PubMed ID: 357821
    [Abstract] [Full Text] [Related]

  • 12. Prolongation of rat renal allograft survival by cyclophosphamide and intravenous donor-specific antigens.
    Bramis JP, Schanzer H, Taub RN.
    Eur Surg Res; 1977 Jun 15; 9(2):140-54. PubMed ID: 15842
    [Abstract] [Full Text] [Related]

  • 13. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H, Woods JE, Khan AU, Holley KE, Leary FJ.
    Transplantation; 1978 Oct 15; 26(4):207-11. PubMed ID: 360522
    [Abstract] [Full Text] [Related]

  • 14. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells.
    van der Linden CJ, Buurman WA, Vegt PA, Greep JM, Jeekel J.
    Transplantation; 1981 Jul 15; 32(1):24-8. PubMed ID: 7022795
    [Abstract] [Full Text] [Related]

  • 15. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP, Baron D, Rouxel A, Guenel J.
    Nephron; 1979 Jul 15; 24(4):193-7. PubMed ID: 386157
    [Abstract] [Full Text] [Related]

  • 16. A randomized prospective study of cadaver donor pretreatment in renal transplantation.
    Jeffery JR, Downs A, Grahame JW, Lye C, Ramsey E, Thomson AE.
    Transplantation; 1978 Jun 15; 25(6):287-9. PubMed ID: 351886
    [Abstract] [Full Text] [Related]

  • 17. Donor pretreatment-mediated and cold storage-dependent proximal tubular necrosis--a unique form of acute renal insufficiency.
    Brom HL, van Breda Vriesman PJ, Brutel de la Rivière G, Terpstra JL.
    Surgery; 1982 Jul 15; 92(1):45-51. PubMed ID: 7046121
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing outcome of kidney allografts from pretreated cadaveric donors.
    Sterioff S, Zincke H, Waltzer WC, Moore SB, Frohnert PP, Offord KP.
    Arch Surg; 1981 Jan 15; 116(1):73-7. PubMed ID: 7008743
    [Abstract] [Full Text] [Related]

  • 19. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
    Swistel AJ, McCabe RE, Lorieo DR, Wildstein A, Pierce JC, Fitzpatrick HF.
    Proc Clin Dial Transplant Forum; 1981 Jan 15; 8():93-5. PubMed ID: 386328
    [No Abstract] [Full Text] [Related]

  • 20. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H, Woods JE, Holley KE.
    Urology; 1977 Oct 15; 10(4):301-4. PubMed ID: 335605
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.